Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
about
Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes.Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
P2860
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@ast
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@en
type
label
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@ast
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@en
prefLabel
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@ast
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@en
P2860
P356
P1476
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.
@en
P2093
Ganesh V Halade
Vasundhara Kain
P2860
P356
10.3389/FCVM.2017.00031
P577
2017-05-31T00:00:00Z